ETON PHARMACEUTICALS INC. - COMMON STOCK
7.0000
04-October-24 15:59:55
15 minutes delayed
Stocks
+0.0900
+1.30%
Today's range
6.7200 - 7.0700
ISIN
N/A
Source
NASDAQ
-
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
28 Jun 2023 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
11 May 2023 16:01:01 By Nasdaq GlobeNewswire
-
10 May 2023 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
03 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
16 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
15 Mar 2023 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
07 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
11 Jan 2023 06:50:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
02 Nov 2022 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
18 Oct 2022 06:50:00 By Nasdaq GlobeNewswire
-
13 Sep 2022 09:00:01 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
30 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
11 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
02 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)
18 Jul 2022 07:05:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Hospital Products
24 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2022 Financial Results
12 May 2022 16:02:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
03 May 2022 16:02:00 By Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
11 Apr 2022 16:01:00 By Nasdaq GlobeNewswire